• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA OIP5-AS1缺失诱导的微小RNA-410积累通过激活PTEN/PI3K/AKT途径靶向KLF10来调节多发性骨髓瘤细胞的增殖和凋亡。

LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.

作者信息

Yang Nan, Chen Jinqiu, Zhang Hui, Wang Xiaman, Yao Huan, Peng Yue, Zhang Wanggang

机构信息

Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, West Five Road, NO.157, Xi'an, China.

出版信息

Cell Death Dis. 2017 Aug 10;8(8):e2975. doi: 10.1038/cddis.2017.358.

DOI:10.1038/cddis.2017.358
PMID:28796257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5596549/
Abstract

Numerous studies confirmed that aberrant miRNAs expression contributes to multiple myeloma (MM) development and progression. However, the roles of specific miRNAs in MM remain to be investigated. In present study, we demonstrated that miR-410 expression was increased in MM newly diagnosed and relapsed tissues and cell lines. Clinical analysis revealed that miR-410 was positively correlated with advanced ISS stage. Moreover, high miR-410 expression in MM patients showed an obvious shorter overall survival and progression-free survival. Gain- and loss-of function experiments indicated that miR-410 promoted cell proliferation, cell cycle progression and apoptosis inhibition both in vitro and in vivo. Moreover, KLF10 was identified as a direct downstream target of miR-410 in MM cells, and mediated the functional influence of miR-410 in MM, resulting in PTEN/AKT activation. In clinical samples of MM, miR-410 inversely correlated with KLF10. Alteration of KLF10 expression or AKT inhibitor at least partially abolished the biological effects of miR-410 on MM cells. Furthermore, downregulated expression of lncRNA OIP5-AS1 was inversely correlated with miR-410 expression in MM tissues. LncRNA OIP5-AS1 could modulate the miR-410 expression and regulate its target KLF10/PTEN/AKT-mediated cellular behaviors. Taken together, this research supports the first evidence that lncRNA OIP5-AS1 loss-induced miR-410 accumulation facilitates cell proliferation, cycle progression and apoptosis inhibition by targeting KLF10 via activating PTEN/PI3K/AKT pathway in MM.

摘要

众多研究证实,异常的微小RNA(miRNA)表达促成了多发性骨髓瘤(MM)的发生和发展。然而,特定miRNA在MM中的作用仍有待研究。在本研究中,我们证明miR-410在新诊断和复发的MM组织及细胞系中表达增加。临床分析显示,miR-410与国际分期系统(ISS)晚期呈正相关。此外,MM患者中miR-410高表达显示总体生存期和无进展生存期明显缩短。功能获得和功能丧失实验表明,miR-410在体外和体内均促进细胞增殖、细胞周期进程并抑制细胞凋亡。此外,KLF10被确定为MM细胞中miR-410的直接下游靶点,并介导miR-410在MM中的功能影响,导致PTEN/AKT激活。在MM临床样本中,miR-410与KLF10呈负相关。KLF10表达改变或使用AKT抑制剂至少部分消除了miR-410对MM细胞的生物学效应。此外,长链非编码RNA(lncRNA)OIP5-AS1在MM组织中的表达下调与miR-410表达呈负相关。LncRNA OIP5-AS1可调节miR-410的表达,并调节其靶向KLF10/PTEN/AKT介导的细胞行为。综上所述,本研究首次证明lncRNA OIP5-AS1缺失诱导的miR-410积累通过激活PTEN/PI3K/AKT通路靶向KLF10,促进MM细胞增殖、周期进程和凋亡抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/764d8d6bbeb5/cddis2017358f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/4f79d962f5f2/cddis2017358f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/b905f8f8fa0d/cddis2017358f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/7865c48a347f/cddis2017358f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/d1b90164c142/cddis2017358f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/bbe130cca4c3/cddis2017358f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/d3a75cce8a0f/cddis2017358f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/9b22edebda88/cddis2017358f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/b2642c13939a/cddis2017358f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/764d8d6bbeb5/cddis2017358f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/4f79d962f5f2/cddis2017358f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/b905f8f8fa0d/cddis2017358f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/7865c48a347f/cddis2017358f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/d1b90164c142/cddis2017358f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/bbe130cca4c3/cddis2017358f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/d3a75cce8a0f/cddis2017358f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/9b22edebda88/cddis2017358f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/b2642c13939a/cddis2017358f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b0/5596549/764d8d6bbeb5/cddis2017358f9.jpg

相似文献

1
LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.长链非编码RNA OIP5-AS1缺失诱导的微小RNA-410积累通过激活PTEN/PI3K/AKT途径靶向KLF10来调节多发性骨髓瘤细胞的增殖和凋亡。
Cell Death Dis. 2017 Aug 10;8(8):e2975. doi: 10.1038/cddis.2017.358.
2
lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.lncRNA OIP5-AS1 通过海绵吸附 miR-200c-3p 调控 PTEN/AKT 抑制子宫内膜癌细胞增殖和侵袭。
J Immunol Res. 2021 Jul 28;2021:4861749. doi: 10.1155/2021/4861749. eCollection 2021.
3
Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.下调的 lncRNA SLC25A5-AS1 通过 miR-19a-3p/PTEN/PI3K/AKT 信号通路促进胃癌细胞生长并抑制细胞凋亡。
J Cell Mol Med. 2019 Apr;23(4):2920-2932. doi: 10.1111/jcmm.14200. Epub 2019 Feb 22.
4
LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.长链非编码 RNA LINC00641 通过 miR-197-3p/KLF10/PTEN/PI3K/AKT 级联预测膀胱癌的预后并抑制其进展。
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1825-1829. doi: 10.1016/j.bbrc.2018.07.120. Epub 2018 Jul 29.
5
Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway.lncRNA FLVCR1-AS1 与 KLF10 之间的正反馈可能通过 PTEN/AKT 通路抑制胰腺癌的进展。
J Exp Clin Cancer Res. 2021 Oct 11;40(1):316. doi: 10.1186/s13046-021-02097-0.
6
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
7
Downregulation of microRNA‑25‑3p inhibits the proliferation and promotes the apoptosis of multiple myeloma cells via targeting the PTEN/PI3K/AKT signaling pathway.miR-25-3p 的下调通过靶向 PTEN/PI3K/AKT 信号通路抑制多发性骨髓瘤细胞的增殖并促进其凋亡。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2020.4841. Epub 2021 Jan 15.
8
Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.肌萎缩蛋白样 1 反义 RNA 1 通过海绵吸附 miR-181a-5p 并调节 PTEN/PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、侵袭和迁移。
Bioengineered. 2021 Dec;12(1):803-814. doi: 10.1080/21655979.2021.1890383.
9
KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p.KLF10 通过 microRNA-106b-5p 的调控抑制多发性骨髓瘤中 PTTG1 的表达从而抑制细胞生长。
Int J Biol Sci. 2020 May 15;16(12):2063-2071. doi: 10.7150/ijbs.45999. eCollection 2020.
10
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.长链非编码 RNA OIP5-AS1 通过海绵吸附 miR-340-5p 诱导 LPAATβ/PI3K/AKT/mTOR 信号通路导致骨肉瘤顺铂耐药。
J Cell Biochem. 2019 Jun;120(6):9656-9666. doi: 10.1002/jcb.28244. Epub 2018 Dec 11.

引用本文的文献

1
Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma.外泌体长链非编码RNA作为多发性骨髓瘤的诊断和治疗靶点
Front Oncol. 2025 Jan 16;14:1522491. doi: 10.3389/fonc.2024.1522491. eCollection 2024.
2
Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma.在临床环境中前行:多发性骨髓瘤诊断和预后生物标志物的最新进展。
Mol Biol Rep. 2024 Sep 9;51(1):972. doi: 10.1007/s11033-024-09892-w.
3
Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies.

本文引用的文献

1
TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway.TIEG1基因缺失通过介导Pten/Akt信号通路,增强梗死心脏的心肌保护作用。
Int J Mol Med. 2017 Mar;39(3):569-578. doi: 10.3892/ijmm.2017.2889. Epub 2017 Feb 13.
2
Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene.Krüpple样因子10通过紫外线辐射抗性相关基因调节胰腺癌的放射敏感性。
Radiother Oncol. 2017 Mar;122(3):476-484. doi: 10.1016/j.radonc.2017.01.001. Epub 2017 Jan 16.
3
MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.
探索G蛋白信号调节因子20的前景:深入了解实体癌和血液系统恶性肿瘤的潜在机制与前景
Cancer Cell Int. 2024 Sep 3;24(1):305. doi: 10.1186/s12935-024-03487-y.
4
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma.OIP5-AS1/miR-455-3p/微原纤维相关蛋白2轴加剧甲状腺癌进展。
Transl Cancer Res. 2024 Jun 30;13(6):3046-3061. doi: 10.21037/tcr-24-630. Epub 2024 Jun 27.
5
MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.微小RNA靶向mTOR作为治疗药物以改善放疗效果。
Cancer Cell Int. 2024 Jul 4;24(1):233. doi: 10.1186/s12935-024-03420-3.
6
Nanoparticles transfected with plasmid-encoded lncRNA-OIP5-AS1 inhibit renal ischemia-reperfusion injury in mice via the miR-410-3p/Nrf2 axis.转染质粒编码长链非编码 RNA-OIP5-AS1 的纳米颗粒通过 miR-410-3p/Nrf2 轴抑制小鼠肾缺血再灌注损伤。
Ren Fail. 2024 Dec;46(1):2319327. doi: 10.1080/0886022X.2024.2319327. Epub 2024 Feb 29.
7
miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer.miR-410是上皮-间质转化的关键调节因子,在前列腺癌中具有双相作用。
Cancers (Basel). 2023 Dec 21;16(1):48. doi: 10.3390/cancers16010048.
8
Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma.非编码RNA的失调:微小RNA和长链非编码RNA在多发性骨髓瘤发病机制中的作用
Noncoding RNA. 2023 Nov 3;9(6):68. doi: 10.3390/ncrna9060068.
9
Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma.Krüppel样因子10作为胰腺腺癌放疗的预后和预测生物标志物
Cancers (Basel). 2023 Oct 30;15(21):5212. doi: 10.3390/cancers15215212.
10
Krüppel-like factor 10 (KLF10) as a critical signaling mediator: Versatile functions in physiological and pathophysiological processes.作为关键信号介质的Krüppel样因子10(KLF10):在生理和病理生理过程中的多种功能。
Genes Dis. 2022 Jul 4;10(3):915-930. doi: 10.1016/j.gendis.2022.06.005. eCollection 2023 May.
在非小细胞肺癌中,微小RNA-410通过抑制糖原合成酶激酶3β但上调β-连环蛋白来诱导干性。
Oncotarget. 2017 Feb 14;8(7):11356-11371. doi: 10.18632/oncotarget.14529.
4
MiR-148a participates in the growth of RPMI8226 multiple myeloma cells by regulating CDKN1B.miR-148a 通过调控 CDKN1B 参与 RPMI8226 多发性骨髓瘤细胞的生长。
Biomed Pharmacother. 2016 Dec;84:1967-1971. doi: 10.1016/j.biopha.2016.11.002. Epub 2016 Nov 11.
5
Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).中晚期肝细胞癌的外科治疗:第五届亚太原发性肝癌专家会议(APPLE 2014)共识报告
Liver Cancer. 2016 Oct;5(4):245-256. doi: 10.1159/000449336. Epub 2016 Sep 14.
6
Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410.长链非编码RNA CCAT1通过抑制微小RNA-410促进胶质瘤细胞增殖。
Biochem Biophys Res Commun. 2016 Nov 25;480(4):715-720. doi: 10.1016/j.bbrc.2016.10.047. Epub 2016 Oct 17.
7
MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.微小RNA-15a/16通过抑制多发性骨髓瘤中Bcl-2、血管内皮生长因子-A和白细胞介素-17的表达来调节骨髓瘤细胞的生长、血管生成和抗肿瘤免疫。
Leuk Res. 2016 Oct;49:73-9. doi: 10.1016/j.leukres.2016.08.013. Epub 2016 Aug 28.
8
SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.在人神经母细胞瘤细胞中,SPARC过表达与辐射相结合通过miR-410抑制VEGF-A来延缓血管生成。
Int J Oncol. 2016 Oct;49(4):1394-406. doi: 10.3892/ijo.2016.3646. Epub 2016 Aug 3.
9
Novel agents in the treatment of multiple myeloma: a review about the future.多发性骨髓瘤治疗中的新型药物:关于未来的综述
J Hematol Oncol. 2016 Jun 30;9(1):52. doi: 10.1186/s13045-016-0282-1.
10
A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma.一项功能性微小RNA文库筛选揭示miR-410是胆管癌一种新的抗凋亡调节因子。
BMC Cancer. 2016 Jun 3;16:353. doi: 10.1186/s12885-016-2384-0.